Stockreport

Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance [Yahoo! Finance]

Clover Health Investments, Corp. - Class A Common stock  (CLOV) 
PDF Issues 2024 guidance with Insurance MCR range of and up to $20 million of Adjusted EBITDA profitability at the high end of the range FRANKLIN, Tenn., March 12, 2024 ( [Read more]